From a clinical perspective, HNK1/HNK1 and HNK2/HNK2 haplotypes seem to be associated with lower cancer risk than LNK1/LNK1 and LNK2/LNK2, respectively (24). This evidence concerns the gene B3GAT1 and cancer.